Dr Reddy's signs US licensing agreement with XenoPort
Drug major Dr Reddy's Laboratories has entered into a US licensing pact with XenoPort for the development and commercialisation of latter's clinical-stage oral new chemical entity XP23829.
Mar 28, 2016, 16:24 PM IST